Literature DB >> 31367605

Subungual Basal Cell Carcinoma: A Rare Nail Tumor with a Challenging Diagnosis.

Talita Pollo1, Fátima Maria de Oliveira Rabay1, Elisangela Manfredini Andraus de Lima1, Fernanda da Rocha Gonçalves2, Samuel Henrique Mandelbaum1.   

Abstract

Subungual basal cell carcinoma (BCC) is a rare disorder associated with many factors, including contact with some topical and oral substances. A differential diagnosis and an early approach are important to minimize the functional damage of the limbs affected by this type of tumor. We report a case of subungual BCC in a 70-year-old woman that was managed by surgical excision. The patient's medical history included the previous use of arsenic. We emphasize the contribution of an early diagnosis to achieve better treatment results in this instance.

Entities:  

Keywords:  Basal cell carcinoma; Nail disorder; Tumor

Year:  2019        PMID: 31367605      PMCID: PMC6615324          DOI: 10.1159/000496707

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  5 in total

1.  Basal cell carcinoma masquerading as habit tic.

Authors:  D Shah; G Leopold; J Sowden
Journal:  Clin Exp Dermatol       Date:  2011-12       Impact factor: 3.470

2.  Surgical treatment of basal cell carcinoma of the nail unit.

Authors:  Ikue Shimizu; Philip R Cohen; Deborah F Macfarlane
Journal:  Int J Dermatol       Date:  2013-08       Impact factor: 2.736

3.  Basal cell carcinoma of the nail unit.

Authors:  Seth B Forman; Tammie C Ferringer; Algin B Garrett
Journal:  J Am Acad Dermatol       Date:  2007-05       Impact factor: 11.527

4.  Periungual basal cell carcinoma.

Authors:  Laura Loures Tavares; Juliana Corrêa Marques da Costa; Nathália Carvalho Delcourt; Nilton Carlos Dos Santos Rodrigues
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

5.  Periungual Basal cell carcinoma: a case report with review of literature.

Authors:  Debabrata Bandyopadhyay; Sumit Sen
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.